Correlation Between Inhibrx and Kandi Technologies

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Kandi Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Kandi Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Kandi Technologies Group, you can compare the effects of market volatilities on Inhibrx and Kandi Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Kandi Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Kandi Technologies.

Diversification Opportunities for Inhibrx and Kandi Technologies

0.44

Correlation Coefficient

Inhibrx  Kandi Technologies

Very weak diversification

The 3 months correlation between Inhibrx and Kandi is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Kandi Technologies Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kandi Technologies and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Kandi Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kandi Technologies has no effect on the direction of Inhibrx i.e., Inhibrx and Kandi Technologies go up and down completely randomly.

Pair Corralation between Inhibrx and Kandi Technologies

Given the investment horizon of 90 days Inhibrx is expected to generate 0.55 times more return on investment than Kandi Technologies. However, Inhibrx is 1.82 times less risky than Kandi Technologies. It trades about -0.09 of its potential returns per unit of risk. Kandi Technologies Group is currently generating about -0.15 per unit of risk. If you would invest  1,743  in Inhibrx on September 15, 2024 and sell it today you would lose (281.00) from holding Inhibrx or give up 16.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Inhibrx  vs.  Kandi Technologies Group

Inhibrx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kandi Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kandi Technologies Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Inhibrx and Kandi Technologies

The main advantage of trading using opposite Inhibrx and Kandi Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Kandi Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kandi Technologies will offset losses from the drop in Kandi Technologies' long position.

The idea behind Inhibrx and Kandi Technologies Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.